Manufacturer
Endo USA, Inc.
7 drugs, 11 product strengths, 11 recalls on record.
Drugs Endo USA, Inc. makes
Posaconazole+1.7%Generic · 28 makersPharmacies pay from$62.01Being discontinued1 open recallErtapenem-6.5%Generic · 16 makersPharmacies pay from$2491 open recallLeuprolideNo changeGeneric · 10 makersPharmacies pay from$198Being discontinuedTheo-24No changeBrand · theophyllinePharmacies pay from$114EdexNo changeBrand · alprostadilPharmacies pay from$366Cortisporin-TCNo changeBrand · colistin / hydrocortisone / neomycin / thonzoniumPharmacies pay from$220Testim-0.1%Brand · testosteronePharmacies pay from$567
Recalls
Class IIOngoingMay 20, 2026Buprenorphine HydrochlorideCrystallization; identified as Buprenorphine free baseENDO USA, Inc. · D-0527-2026Class IIIOngoingNov 5, 2025Everolimus tablets 5mgFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.Endo USA, Inc. · D-0139-2026Class IIIOngoingNov 5, 2025Everolimus tablets 7.5mgFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.Endo USA, Inc. · D-0140-2026Class IIIOngoingNov 5, 2025Everolimus tablets 10 mgFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.Endo USA, Inc. · D-0141-2026Class IIIOngoingNov 5, 2025Everolimus tablets 2.5 mgFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.Endo USA, Inc. · D-0142-2026Class IIIOngoingOct 22, 2025Everolimus tablets 5mgFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.Endo USA, Inc. · D-0026-2026Class IOngoingFeb 12, 2025Adrenalin Chloride SolutionLabeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)ENDO USA, Inc. · D-0223-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0178-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0179-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0180-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0181-2025
About Endo USA, Inc.
No comments yet. Questions, tips, what worked for you - start the conversation.